The collaboration will give attention to weight problems prevention, together with more healthy early-life environments, bodily exercise promotion, early danger identification, and preparedness inside major well being care programs
The WHO Basis and Novo Nordisk are collaborating to boost consciousness on childhood weight problems in India.
The collaboration would offering monetary assist in direction of strengthening of weight problems prevention and health-system readiness in India, to curb the rise of childhood weight problems by a scalable school-based well being program, they mentioned in a joint communication. The initiative is a part of Novo Nordisk’s CSR (company social duty), an trade consultant mentioned.
In accordance with the World Well being Group, obese and weight problems now trigger extra deaths globally than underweight and are linked to a number of noncommunicable ailments, together with heart problems and sort 2 diabetes. The WHO Basis is an unbiased organisation headquartered in Geneva, Switzerland, created in 2020 to assist the mission of the World Well being Group.
The communication identified that the collaboration will give attention to weight problems prevention, together with more healthy early-life environments, bodily exercise promotion, early danger identification, and preparedness inside major well being care programs.
The collaboration comes whilst globally fashionable weightloss and diabetes medicine (for adults) Wegovy and Ozempic from Novo Nordisk, and Eli Lilly’s Mounjaro make fast strides within the home market. In truth, extra variations of semaglutide, the energetic ingredient in Novo’s Wegovy and Ozempic, are anticipated to flood the native market from Indian drugmakers, as a primary patent on semaglutide is ready to run out in days, in markets together with India.
Anil Soni, Chief Govt Officer of the WHO Basis, mentioned: “Colleges are the frontline of prevention. By integrating well being screening and schooling instantly into the college day, this collaboration goals to guard the well-being of the following technology, turning faculties into enabling environments for wholesome dwelling.”
Vikrant Shrotriya, Managing Director of Novo Nordisk India, mentioned, “India is witnessing a worrying rise in childhood and adolescent weight problems, and addressing this problem early is important to safeguard the nation’s long-term well being.”
Revealed on March 11, 2026
